Abstract

The use of cholinesterase inhibitors and antioxidants is currently considered as an effective therapeutic strategy for the treatment of Alzheimer’s disease (AD). There is also a growing trend to use nutraceuticals for cognitive impairment. Since natural product-based drugs offer better hope for the treatment of AD, the present study was aimed at evaluating the nutritional profile of the brown seaweed Padina gymnospora and investigating the antioxidant and inhibitory effect of different solvent extracts of P. gymnospora on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes. The nutritional profile of P. gymnospora includes large amounts of carbohydrate, protein, lipid, proline, chlorophyll, fibre, minerals, fatty acids and amino acids, along with antioxidants such as vitamins C and E. Antioxidant activities of various solvent extracts of P. gymnospora were assessed by the DPPH scavenging assay, nitric oxide scavenging assay, reducing power assay and FRAP assay. Acetone extracts showed significant DPPH radical and nitric oxide scavenging activity with IC50 values of 402 ± 9.12 and 441 ± 48.16 µg ml–1 respectively and aqueous extracts had better reducing potential. Among the different solvent extracts, the acetone extract showed the highest inhibitory activity with IC50 values <150 µg ml–1 for both AChE and BuChE. Qualitative phytochemical screening of P. gymnospora revealed the presence of flavonoids and cardiac glycosides. Overall the results suggest that the seaweed Padina gymnospora may be a good nutraceutical candidate for discovering drugs against AD.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call